--- title: "Pre-market hot trades in US stocks: Baosheng Media up 11.04% pre-market; Planet Green down 5.40% pre-market" type: "News" locale: "en" url: "https://longbridge.com/en/news/294506384.md" description: "Baosheng Media pre-market rose 11.04%; Planet Green pre-market fell 5.40%; Microbus pre-market rose 240.00%; Replimune pre-market rose 134.01%; Mangoceuticals pre-market rose 80.52%" datetime: "2026-07-31T11:33:03.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/294506384.md) - [en](https://longbridge.com/en/news/294506384.md) - [zh-HK](https://longbridge.com/zh-HK/news/294506384.md) --- # Pre-market hot trades in US stocks: Baosheng Media up 11.04% pre-market; Planet Green down 5.40% pre-market **Popular Pre-Market Trades in US Stocks** Baosheng Media, up 11.04% in pre-market trading, has no significant news recently. The trading is active with clear capital flows, and considering the sector and industry trends, the stock shows significant volatility, with specific reasons needing further observation. Planet Green, down 5.40% in pre-market trading. Based on recent key news: 1. On July 28, Planet Green announced that its latest seabed battery metal mining plan encountered technical difficulties, raising market concerns about its future profitability. This news triggered panic among investors, causing the stock price to drop. 2. On July 27, a major competitor of Planet Green released a strong quarterly report, showing significant market share growth. This raised doubts among investors about Planet Green's market competitiveness, further suppressing the stock price. 3. On July 26, analysts downgraded Planet Green's rating due to tight cash flow and slow progress in clinical trials. The downgrade led to a decline in investor confidence, causing the stock price to continue to fall. The market's adaptation to AI technology has not gone smoothly, leading to overall volatility. **Top Gainers in Pre-Market US Stocks** WeTour Robotics, up 240.00% in pre-market trading. Based on recent key news: 1. On July 30, Wetour Robotics announced a common stock consolidation plan with a ratio of 1 for 100, expected to take effect on August 3. This move aims to enhance stock price stability, boost market confidence, and drive the stock price up. 2. On July 29, the SEC issued a notice reminding investors to be cautious about forward-looking statements and emphasized that the company discussed additional factors in its SEC filings. This announcement increased market confidence in the company's transparency and compliance, further driving the stock price up. 3. On July 29, Fermi and Galaxy Digital showed uncertainty in response to changes in cryptocurrency regulation, with traditional commodity tools providing mixed signals. Investors sought safe havens, turning to more stable assets, indirectly pushing WeTour Robotics' stock price up. Changes in cryptocurrency regulation affected market sentiment, with traditional commodity tools providing mixed signals. Replimune, up 134.01% in pre-market trading. Based on recent key news: 1. On July 31, an external advisory panel for the FDA supported the trial results of Replimune's RP1 drug, driving the stock price up significantly. This drug is used for treating advanced melanoma, with a final decision expected on August 2. Cantor Fitzgerald believes the FDA will almost certainly adopt the panel's recommendations. 2. On July 28, FDA staff expressed concerns about the efficacy of the RP1 drug, leading to a drop in stock price. Review documents indicated that the trial results might have exaggerated the drug's response rate and durability. 3. On July 30, Replimune announced favorable results from the FDA advisory committee meeting, with support for the RP1 drug application in advanced melanoma, causing the stock price to rise significantly. The biopharmaceutical industry faces regulatory challenges and high volatility Mangoceuticals pre-market rose by 80.52%. There has been no significant news recently; trading is active, and capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. no\_news ### Related Stocks - [BAOS.US](https://longbridge.com/en/quote/BAOS.US.md) - [PLAG.US](https://longbridge.com/en/quote/PLAG.US.md) - [WETO.US](https://longbridge.com/en/quote/WETO.US.md) - [REPL.US](https://longbridge.com/en/quote/REPL.US.md) - [MGRX.US](https://longbridge.com/en/quote/MGRX.US.md) ## Related News & Research - [These 2 Stocks Just Broke Out — and They Could Go Higher, Say Analysts](https://longbridge.com/en/news/294640053.md) - [Why Replimune (REPL) Is Up 15.5% After Supportive FDA Panel Vote On IGNYTE Melanoma Data](https://longbridge.com/en/news/294586250.md) - [ImmunityBio Achieves World's Broadest Bladder Cancer Approval as UAE Green Lights Lead Drug](https://longbridge.com/en/news/294398878.md) - [Incyte expects Opzelura to cross $1B in 2026](https://longbridge.com/en/news/294223769.md) - [Viking Therapeutics: Why This Clinical-Stage, Licensed-Technology Play Is a Highly Speculative Bet for Equity Investors](https://longbridge.com/en/news/294468534.md)